Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Y-Mabs Therapeutics Inc (YMAB)  
$12.01 0.26 (2.12%) as of 4:30 Thu 5/30


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 40,010,000
Market Cap: 480.52(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $4.86 - $18.69
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 15.9
Insider 3/6 Months : 16.5
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Y-mAbs Therapeutics is a commercial-stage biopharmaceutical company focused on the development and commercialization of antibody based therapeutic products for the treatment of cancer. Co.'s approved drug DANYELZA® (naxitamab-gqgk) was approved by the U.S. Food and Drug Administration for the treatment, in combination with Granulocyte-Macrophage Colony-Stimulating Factor of pediatric patients one year of age and older and adult patients with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow who have demonstrated a partial response, minor response, or stable disease to prior therapy.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 371,682 558,056 762,731
Total Buy Value $0 $2,488,242 $3,530,830 $5,499,522
Total People Bought 0 2 2 3
Total Buy Transactions 0 10 14 17
Total Shares Sold 39,644 189,644 339,644 339,644
Total Sell Value $515,799 $1,516,799 $2,312,182 $2,312,182
Total People Sold 3 3 3 3
Total Sell Transactions 5 8 10 10
End Date 2024-02-29 2023-11-28 2023-05-30 2022-05-30

   
Records found: 251
  Page 5 of 11  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Gad Thomas See remarks   •       •      –    2021-06-14 4 AS $35.80 $143,217 I/I (4,000) 1,599,927 -28%     
   Wedell-Wedellsborg Johan Director   –       •      –    2021-06-10 4 S $36.15 $405,971 I/I (11,229) 4,178,465 29%     
   Wg Biotech Aps See remarks   –       •      –    2021-06-10 4 S $36.15 $405,971 D/D (11,229) 4,178,456 29%     
   Wedell-Wedellsborg Johan Director   –       •      –    2021-06-09 4 S $36.19 $4,223,116 I/I (116,700) 4,189,694 27%     
   Wg Biotech Aps See Remarks   –       •      –    2021-06-09 4 S $36.19 $4,223,116 D/D (116,700) 4,189,694 27%     
   Wedell-Wedellsborg Johan Director   –       •      –    2021-06-08 4 S $35.28 $1,174,694 I/I (33,300) 4,306,394 22%     
   Wg Biotech Aps See Remarks   –       •      –    2021-06-08 4 S $35.28 $1,174,694 D/D (33,300) 4,306,394 22%     
   Wg Biotech Aps 10% Owner   –       –       •   2021-06-07 4 S $34.15 $2,472,583 D/D (72,400) 4,339,694 22%     
   Wedell-Wedellsborg Johan Director   –       •      –    2021-06-07 4 S $34.15 $2,472,583 I/I (72,400) 4,339,694 22%     
   Wedell-Wedellsborg Johan Director   –       •      –    2021-06-04 4 S $34.03 $130,704 I/I (3,841) 4,412,094 18%     
   Kruse Bo EVP, CFO, Secretary & Treas.   •       –      –    2021-06-04 4 AS $33.48 $133,920 D/D (4,000) 249,077 -18%     
   Wg Biotech Aps 10% Owner   –       –       •   2021-06-04 4 S $34.03 $130,704 D/D (3,841) 4,412,094 18%     
   Wedell-Wedellsborg Johan Director   –       •      –    2021-06-03 4 S $33.19 $1,017,670 I/I (30,666) 4,415,935 19%     
   Wg Biotech Aps 10% Owner   –       –       •   2021-06-03 4 S $33.19 $1,017,670 D/D (30,666) 4,415,935 19%     
   Wg Biotech Aps 10% Owner   –       –       •   2021-06-01 4 S $35.57 $244,173 D/D (6,864) 4,446,601 21%     
   Wedell-Wedellsborg Johan Director   –       •      –    2021-06-01 4 S $35.57 $244,173 I/I (6,864) 4,446,601 21%     
   Wg Biotech Aps 10% Owner   –       –       •   2021-05-28 4 S $36.34 $908,475 D/D (25,000) 4,453,465 22%     
   Wedell-Wedellsborg Johan Director   –       •      –    2021-05-28 4 S $36.34 $908,475 I/I (25,000) 4,453,465 22%     
   Gad Thomas See remarks   •       •      –    2021-05-28 4 AS $36.95 $147,813 I/I (4,000) 1,603,927 -22%     
   Kruse Bo EVP, CFO, Secretary & Treas.   •       –      –    2021-05-24 4 AS $35.61 $142,440 D/D (4,000) 253,077 -19%     
   Gad Thomas See remarks   •       •      –    2021-05-18 4 AS $34.07 $136,290 I/I (4,000) 1,607,927 -14%     
   Gad Thomas See remarks   •       •      –    2021-04-26 4 AS $27.96 $195,731 D/D (7,000) 0 17%     
   Gad Thomas See remarks   •       •      –    2021-04-26 4 OE $2.00 $14,000 D/D 7,000 7,000     -
   Gad Thomas See remarks   •       •      –    2021-04-12 4 AS $26.60 $106,388 I/I (4,000) 1,611,927 4%     
   Gad Thomas See remarks   •       •      –    2021-04-12 4 AS $26.61 $186,253 D/D (7,000) 0 4%     
  251 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 5 of 11
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us